i just don't understand why they are not using int
Post# of 153824
(Total Views: 694)
Posted On: 04/03/2021 6:17:57 PM
Re: MD VIROLOGIST #85147
i just don't understand why they are not using intravenous for critically ill patients.
The PRO140 HIV human trials already dosed at least 15 or 20 patients by intravenous so there is an excellent safety record there.
Critically ill covid patients are so much sicker than cancer paitents and the FDA lets people try all kinds of poison on the cancer patients.
Critical covid is an emergency condition. The FDA should be acting quickly, not giving people subcutaneous injections.
How is it conceivable that the FDA will not let human trials go on patients in far, far worse shape than cancer patients when the drug has a massively better safety record than cancer drugs?
This just doesn't make any sense.
Maybe Cytodyn is somehow pushing for subcutaneous? Lalezari has been pushing IV since day one so if it was up to him we would have had IV a long time ago.
Why in the heck is CD16 not intravenous?
It just doesn't make any sense.
The pharmacokinetics from the PRO140 HIV human trials (blood concentration vs. time) show nearly identical for intravenous vs. subcutaneous.
The PRO140 HIV human trials already dosed at least 15 or 20 patients by intravenous so there is an excellent safety record there.
Critically ill covid patients are so much sicker than cancer paitents and the FDA lets people try all kinds of poison on the cancer patients.
Critical covid is an emergency condition. The FDA should be acting quickly, not giving people subcutaneous injections.
How is it conceivable that the FDA will not let human trials go on patients in far, far worse shape than cancer patients when the drug has a massively better safety record than cancer drugs?
This just doesn't make any sense.
Maybe Cytodyn is somehow pushing for subcutaneous? Lalezari has been pushing IV since day one so if it was up to him we would have had IV a long time ago.
Why in the heck is CD16 not intravenous?
It just doesn't make any sense.
The pharmacokinetics from the PRO140 HIV human trials (blood concentration vs. time) show nearly identical for intravenous vs. subcutaneous.
(4)
(0)